Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone in idiosyncratic drug-induced liver injury
NCT06251232Phase 2Not yet recruiting
- Start
- May 2024
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of prednisone in drug induced liver injury (DILI). Planned start May 2024; status: not yet recruiting.
02
Drugs
prednisone
03
Conditions
drug induced liver injury (DILI)
Beyond the preview
Go deeper on NCT06251232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06251232.